Laidlaw Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,693
Closed -$534K 111
2024
Q4
$534K Buy
3,693
+239
+7% +$37K 0.23% 102
2024
Q3
$560K Sell
3,454
-334
-9% -$53.2K 0.28% 100
2024
Q2
$554K Sell
3,788
-662
-15% -$98.5K 0.3% 93
2024
Q1
$704K Sell
4,450
-5,140
-54% -$818K 0.39% 76
2023
Q4
$1.5M Sell
9,590
-2,319
-19% -$356K 0.55% 50
2023
Q3
$1.85M Sell
11,909
-13,321
-53% -$2.2M 0.61% 42
2023
Q2
$4.18M Buy
25,230
+777
+3% +$125K 0.82% 25
2023
Q1
$3.79M Buy
24,453
+334
+1% +$53.9K 0.77% 26
2022
Q4
$4.26M Buy
24,119
+554
+2% +$95.7K 0.91% 20
2022
Q3
$3.85M Buy
23,565
+327
+1% +$55.3K 0.9% 20
2022
Q2
$4.13M Buy
23,238
+2,214
+11% +$394K 0.84% 23
2022
Q1
$3.73M Buy
21,024
+447
+2% +$76.1K 0.62% 35
2021
Q4
$3.52M Sell
20,577
-2,816
-12% -$461K 0.56% 45
2021
Q3
$3.78M Buy
+23,393
New +$3.99M 0.97% 26
2021
Q1
Sell
-22,549
Closed -$3.55M 295
2020
Q4
$3.55M Buy
22,549
+9,656
+75% +$1.42M 0.75% 26
2020
Q3
$1.92M Buy
12,893
+123
+1% +$18.2K 0.85% 30
2020
Q2
$1.8M Buy
12,770
+1,036
+9% +$151K 0.94% 30
2020
Q1
$1.54M Buy
11,734
+202
+2% +$28.7K 1.01% 28
2019
Q4
$1.68M Buy
+11,532
New +$1.56M 1.06% 24

Other funds holding JNJ

Laidlaw Wealth Management's JNJ Position: Q1 2025 in Review

Laidlaw Wealth Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 3,693 shares — an estimated $534K sold.

Laidlaw Wealth Management first reported a position in JNJ in Q4 2019 and held it in 19 quarters. The position peaked at $4.26M in Q4 2022. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Laidlaw Wealth Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Laidlaw Wealth Management sold 3,693 Johnson & Johnson shares in Q1 2025, an estimated $534K.
  • Laidlaw Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 19 quarters.
  • Laidlaw Wealth Management's Johnson & Johnson position peaked at $4.26M in Q4 2022.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.